The agreements follow its post-IPO review after its £16.5m fundraise and admission to the main market on LSE in May...
Kalia joined international provider of cannabis products Curaleaf Holdings, Inc. as CFO on 19 July.
The Canxchange Farmers Sentiment Index (CFSI) shows a fairly optimistic outlook from European hemp farmers.
The Apollon medical cannabis formulations are an opportunity for more men to have their prostate cancer treated.
MGC Pharma anticipates that the patent for its novel SNEDDS formulation will be issued within the coming 12 months.
Lawyer from London law firm Bishop & Sewell, Eleanor Furlong, says the deregulation of cannabis in the UK is a case of ‘when, not if’.
CanCoin, a new token that utilises blockchain technology, has been launched to accelerate the European cannabis industry.
The first cannabis company to IPO on LSE, Kanabo, has launched a new extract formula that will give thousands of UK patients access to pain relief...
Solar Therapeutics used an image of Cohen's fictional character Borat in an advertising campaign
The move suggests that the medical establishment has finally put its faith in cannabis
Stakeholders from across the sector have set out their agenda for creating a more robust UK industry
The company is on track to become a world-leading, vertically integrated seed to sales operation
Oxford Cannabinoid Technologies has signed a deal with drug development firm Evotec as it moves towards Phase 1 clinical trials in humans.